Paper41585665
Drug Delivery System for the Anticancer Drug Paclitaxel Using Lipocalin-Type Prostaglandin D Synthase Conjugated to a Tumor-Targeting Peptide.
Furuta K and 6 others. ACS Omega, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Drug Delivery System for the Anticancer Drug Paclitaxel Using Lipocalin-Type Prostaglandin D Synthase Conjugated to a Tumor-Targeting Peptide. Papers, record 41585665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585665
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Drug Delivery System for the Anticancer Drug Paclitaxel Using Lipocalin-Type Prostaglandin D Synthase Conjugated to a Tumor-Targeting Peptide.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24163786 | Paclitaxel Nano-Delivery Systems: A Comprehensive Review. | J Nanomed Nanotechnol | 2013 | https://conductscience.org/library/papers/24163786 | PubMed |
| 2 | 28829147 | Comprehensive Evaluation of the Binding of Lipocalin-Type Prostaglandin D Synthase to Poorly Water-Soluble Drugs. | Mol Pharm | 2017 | https://conductscience.org/library/papers/28829147 | PubMed |
| 3 | 11345647 | Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. | Cancer Chemother Pharmacol | 2001 | https://conductscience.org/library/papers/11345647 | PubMed |
| 4 | 30957264 | Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30957264 | PubMed |
| 5 | 18976707 | Dendrimers as versatile platform in drug delivery applications. | Eur J Pharm Biopharm | 2009 | https://conductscience.org/library/papers/18976707 | PubMed |
| 6 | 17826969 | Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. | Eur J Pharm Biopharm | 2008 | https://conductscience.org/library/papers/17826969 | PubMed |
| 7 | 20797419 | To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. | J Control Release | 2010 | https://conductscience.org/library/papers/20797419 | PubMed |
| 8 | 11879753 | Paclitaxel and its formulations. | Int J Pharm | 2002 | https://conductscience.org/library/papers/11879753 | PubMed |
| 9 | 19499576 | AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. | J Comput Chem | 2010 | https://conductscience.org/library/papers/19499576 | PubMed |
| 10 | 21812415 | Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. | Acc Chem Res | 2011 | https://conductscience.org/library/papers/21812415 | PubMed |
| 11 | 19962669 | Tissue-penetrating delivery of compounds and nanoparticles into tumors. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19962669 | PubMed |
| 12 | 21959118 | Impact of albumin on drug delivery--new applications on the horizon. | J Control Release | 2012 | https://conductscience.org/library/papers/21959118 | PubMed |
| 13 | 11357884 | Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions. | Int Immunopharmacol | 2001 | https://conductscience.org/library/papers/11357884 | PubMed |
| 14 | 19572330 | Protein-based nanomedicine platforms for drug delivery. | Small | 2009 | https://conductscience.org/library/papers/19572330 | PubMed |
| 15 | 12441340 | Characterization of the unfolding process of lipocalin-type prostaglandin D synthase. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12441340 | PubMed |
| 16 | 28802714 | In silico structure-based approaches to discover protein-protein interaction-targeting drugs. | Methods | 2017 | https://conductscience.org/library/papers/28802714 | PubMed |
| 17 | 22677050 | Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands. | Biochem J | 2012 | https://conductscience.org/library/papers/22677050 | PubMed |
| 18 | 7904378 | Paclitaxel (TAXOL): side effects and patient education issues. | Semin Oncol Nurs | 1993 | https://conductscience.org/library/papers/7904378 | PubMed |
| 19 | 22378269 | Diagnosing the decline in pharmaceutical R&D efficiency. | Nat Rev Drug Discov | 2012 | https://conductscience.org/library/papers/22378269 | PubMed |
| 20 | 24530534 | Fine-tuned broad binding capability of human lipocalin-type prostaglandin D synthase for various small lipophilic ligands. | FEBS Lett | 2014 | https://conductscience.org/library/papers/24530534 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NRP1 | 8829 | PubTator's text mining | https://conductscience.org/library/genes/8829 | NCBI Gene |
| PTGDS | 5730 | PubTator's text mining | https://conductscience.org/library/genes/5730 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41585665
GET https://conductscience.org/api/papers/v1/41585665/references?page=2